ImpactOS
See an example

MedTech Europe

Trade and business associations · Belgium

In these lists: Medicines

Declared lobbying cost
€1,500,000 – €1,749,999 Financial year 01/2024-12/2024
Commission meetings
30
Full-time staff on EU lobbying
2.95
European Parliament access passes
5
EU funding received
€11,303
Registered since
26 Dec 2016
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Budget, Business and industry, Communication, Competition, Consumers, Digital economy and society, Economy, finance and the euro, Employment and social affairs, Environment, Institutional affairs, Public health, Regional policy, Research and innovation, Single market, Taxation, Trade

Medicines and food topics they name

EU medicines law, Orphan and paediatric medicine incentives, Health technology assessment, Antibiotics and antimicrobials

EU laws and policies they declare following15
  • Healthcare, and Medical Technologies
  • Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices.
  • Regulation (EU) 2017/745 on Medical Devices.
  • Regulation 2021/2282 on Health Technology Assessment (HTA).
  • Pharmaceutical Strategy for Europe, including the revision of related legislative frameworks (e.g., orphan and paediatric medicinal products).
  • European Health Data Space Regulation.
  • Blood, tissues, and cells legislation.
  • Policies addressing Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HAIs) and non-communicable diseases (NCDs).
  • Directive on Cross-Border Health Care.
  • HERA Regulation (Health Emergency Preparedness and Response Authority).
  • Digital Health, Innovation, and Cybersecurity
  • Artificial Intelligence Act.
  • Cyber Resilience Act.
  • Data Act.
  • Directive on measures for a high common level of cybersecurity across the Union (NIS Directive 2).

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Cabinet

    Ekaterina Zaharieva

    Horizon Europe partnerships

    Published record
  2. With the Cabinet

    Olivér Várhelyi

    Preventive health and early detection

    Published record
  3. With the Commissioner

    Olivér Várhelyi

    Medtech CEO meeting

    Published record
  4. With the Cabinet

    Olivér Várhelyi

    Medtech CEO meeting

    Published record
  5. With the Commissioner

    Olivér Várhelyi

    Health industry roundtable

    Published record
  6. With the Cabinet

    Olivér Várhelyi

    Health industry roundtable

    Published record
  7. With the Cabinet

    Stéphane Séjourné

    Revision of the public procurement framework

    Published record
  8. With the Commissioner

    Olivér Várhelyi

    Health industry roundtable

    Published record
  9. With the Cabinet

    Olivér Várhelyi

    Health industry roundtable

    Published record
  10. With the Commissioner

    Olivér Várhelyi

    Medical devices reform

    Published record

See all 30 meetings

Official entries

Checked against sources on 11 Nov 2026